Stocks
LifeStance Health Group Financial Statements (LFST) |
||||||||||
| LifeStance Health Groupsmart-lab.ru | % | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 10.05.2023 | 09.08.2023 | 08.11.2023 | 28.02.2024 | 09.05.2024 | 09.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 252.6 | 259.6 | 262.9 | 280.6 | 300.4 | 1 104 | |||
| Operating Income, bln rub | -34.1 | -48.4 | -74.4 | -31.3 | -16.7 | -170.7 | ||||
| EBITDA, bln rub | ? | -15.1 | -28.9 | -54.7 | -9.07 | 5.89 | -86.8 | |||
| Net profit, bln rub | ? | -34.2 | -45.5 | -61.6 | -45.0 | -21.1 | -173.1 | |||
| OCF, bln rub | ? | -7.89 | -0.434 | -25.4 | 16.8 | -21.8 | -30.8 | |||
| CAPEX, bln rub | ? | 7.73 | 11.6 | 9.80 | 11.4 | 5.10 | 37.9 | |||
| FCF, bln rub | ? | -15.6 | -12.0 | -35.2 | 5.38 | -26.9 | -68.7 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 103.7 | 121.4 | 150.6 | 92.4 | 88.8 | 453.2 | ||||
| Cost of production, bln rub | 183.0 | 186.6 | 186.7 | 219.5 | 228.3 | 821.1 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 5.09 | 5.12 | 5.48 | 5.53 | 5.90 | 22.0 | ||||
| Assets, bln rub | 2 159 | 2 171 | 2 175 | 2 233 | 2 106 | 2 106 | ||||
| Net Assets, bln rub | ? | 1 505 | 1 495 | 1 455 | 1 429 | 1 429 | 1 429 | |||
| Debt, bln rub | 474.3 | 497.8 | 483.5 | 511.0 | 505.8 | 505.8 | ||||
| Cash, bln rub | 68.3 | 79.6 | 42.6 | 78.8 | 49.5 | 49.5 | ||||
| Net debt, bln rub | 406.0 | 418.1 | 440.9 | 432.2 | 456.3 | 456.3 | ||||
| Ordinary share price, rub | 7.43 | 9.13 | 6.87 | 7.83 | 6.17 | 5.95 | ||||
| Number of ordinary shares, mln | 360.9 | 363.2 | 372.5 | 378.7 | 376.3 | 376.3 | ||||
| Market cap, bln rub | 2 682 | 3 316 | 2 559 | 2 965 | 2 322 | 2 239 | ||||
| EV, bln rub | ? | 3 088 | 3 734 | 3 000 | 3 398 | 2 778 | 2 695 | |||
| Book value, bln rub | -42 | -42 | -72 | -85 | -73 | -73 | ||||
| EPS, rub | ? | -0.09 | -0.13 | -0.17 | -0.12 | -0.06 | -0.46 | |||
| FCF/share, rub | -0.04 | -0.03 | -0.09 | 0.01 | -0.07 | -0.18 | ||||
| BV/share, rub | -0.12 | -0.12 | -0.19 | -0.23 | -0.19 | -0.19 | ||||
| EBITDA margin, % | ? | -5.97% | -11.1% | -20.8% | -3.23% | 1.96% | -7.87% | |||
| Net margin, % | ? | -13.6% | -17.5% | -23.4% | -16.0% | -7.02% | -15.7% | |||
| FCF yield, % | ? | -0.65% | -0.35% | -1.46% | -1.94% | -2.96% | -3.07% | |||
| ROE, % | ? | -12.5% | -11.0% | -12.9% | -13.0% | -12.1% | -12.1% | |||
| ROA, % | ? | -8.69% | -7.56% | -8.64% | -8.34% | -8.22% | -8.22% | |||
| P/E | ? | -14.3 | -20.2 | -13.6 | -15.9 | -13.4 | -12.9 | |||
| P/FCF | -153.4 | -289.2 | -68.7 | -51.7 | -33.8 | -32.6 | ||||
| P/S | ? | 2.95 | 3.46 | 2.55 | 2.81 | 2.10 | 2.03 | |||
| P/BV | ? | -63.2 | -78.2 | -35.5 | -34.7 | -31.9 | -30.7 | |||
| EV/EBITDA | ? | -28.8 | -40.5 | -23.8 | -31.5 | -32.0 | -31.0 | |||
| Debt/EBITDA | -3.79 | -4.53 | -3.50 | -4.01 | -5.26 | -5.26 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| CAPEX/Revenue, % | 3.06% | 4.46% | 3.73% | 4.07% | 1.70% | 3.43% | ||||
| LifeStance Health Group shareholders | ||||||||||
